These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 16418817
1. [Gastrointestinal stromal tumors (GIST). Clinical characteristics, diagnosis, and therapy in five cases]. Ludolph T, Schweitzer A, Bremer A, Schulz U, Glasbrenner B. Med Klin (Munich); 2006 Jan 15; 101(1):69-74. PubMed ID: 16418817 [Abstract] [Full Text] [Related]
2. Familial gastrointestinal stromal tumor syndrome: report of 2 cases with KIT exon 11 mutation. Jones DH, Caracciolo JT, Hodul PJ, Strosberg JR, Coppola D, Bui MM. Cancer Control; 2015 Jan 15; 22(1):102-8. PubMed ID: 25504284 [Abstract] [Full Text] [Related]
3. Gastrointestinal stromal tumors: diagnosis and treatment. Acín-Gándara D, Pereira-Pérez F, Castaño-Pascual A, Durán-Poveda M, Antequera-Pérez A, Miliani-Molina C. Cir Cir; 2012 Jan 15; 80(1):44-51. PubMed ID: 22472152 [Abstract] [Full Text] [Related]
4. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)]. Mac K, Wójcik M. Postepy Hig Med Dosw (Online); 2007 Jun 09; 62():272-81. PubMed ID: 18542042 [Abstract] [Full Text] [Related]
5. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Gold JS, Dematteo RP. Ann Surg; 2006 Aug 09; 244(2):176-84. PubMed ID: 16858179 [Abstract] [Full Text] [Related]
6. [Gastrointestinal stromal tumors: report of three cases and review of the literature]. Zanghì G, Di Stefano G, Strazzanti A, Benfatto G, Politi V, Basile F. G Chir; 2006 May 09; 27(5):209-13. PubMed ID: 16857109 [Abstract] [Full Text] [Related]
7. [Surgery on gastrountestinal stromal tumor CD117+ (G.I.S.T.): personal experience]. Cavallaro A, Lauretta A, Cavallaro M, Pennisi S, Cavallaro V. Ann Ital Chir; 2006 May 09; 77(2):137-41. PubMed ID: 17147087 [Abstract] [Full Text] [Related]
9. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST). Rutkowski P, Nyckowski P, Grzesiakowska U, Nowecki ZI, Nasierowska-Guttmejer A, Pienkowski A, Dudek K, Krawczyk M, Ruka W. Neoplasma; 2003 May 09; 50(6):438-42. PubMed ID: 14689066 [Abstract] [Full Text] [Related]
10. [Gastrointestinal stromal tumor of small intestine associated with lymph node metastasis: a report of 2 cases with review of literatures]. Kong M, Wang YL, Xu LJ, Teng XD. Zhonghua Bing Li Xue Za Zhi; 2009 Sep 09; 38(9):617-20. PubMed ID: 20079191 [Abstract] [Full Text] [Related]
12. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease. Cao H, Zhang Y, Wang M, Shen DP, Sheng ZY, Ni XZ, Wu ZY, Liu Q, Shen YY, Song YY. Chin Med J (Engl); 2010 Jan 20; 123(2):131-6. PubMed ID: 20137358 [Abstract] [Full Text] [Related]
13. [The diagnostic and predictive role of kit (CD117)]. Dirnhofer S, Zimpfer A, Went P. Ther Umsch; 2006 Apr 20; 63(4):273-8. PubMed ID: 16689459 [Abstract] [Full Text] [Related]
14. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Demetri GD. Semin Oncol; 2001 Oct 20; 28(5 Suppl 17):19-26. PubMed ID: 11740803 [Abstract] [Full Text] [Related]
15. [Gastrointestinal stromal tumors (GIST) - clinical experience and current therapeutical aspects]. Iarŭmov N, Velev G, Todorov G, Lukanova Ts, Angelov K, Gribnev P, Sokolov M, Toshev S. Khirurgiia (Sofiia); 2007 Oct 20; (4):27-32. PubMed ID: 18443532 [Abstract] [Full Text] [Related]
16. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, DeMatteo RP. Clin Cancer Res; 2005 Jun 01; 11(11):4182-90. PubMed ID: 15930355 [Abstract] [Full Text] [Related]
17. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib. Schindler CG, Armbrust T, Gunawan B, Langer C, Füzesi L, Ramadori G. Z Gastroenterol; 2005 Mar 01; 43(3):267-73. PubMed ID: 15765299 [Abstract] [Full Text] [Related]
18. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hornick JL, Fletcher CD. Hum Pathol; 2007 May 01; 38(5):679-87. PubMed ID: 17437861 [Abstract] [Full Text] [Related]
19. [Gastrointestinal stromal tumors in neurofibromatosis type 1]. Bajor J. Orv Hetil; 2009 Jan 25; 150(4):149-53. PubMed ID: 19144598 [Abstract] [Full Text] [Related]
20. Emergence of imatinib resistance associated with downregulation of c-kit expression in recurrent gastrointestinal stromal tumor (GIST): optimal timing of resection. Dudeja V, Armstrong LH, Gupta P, Ansel H, Askari S, Al-Refaie WB. J Gastrointest Surg; 2010 Mar 25; 14(3):557-61. PubMed ID: 20033343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]